Wednesday, Definitive Healthcare Corp (NASDAQ:DH) reported fourth-quarter 2023 adjusted EPS of $0.07, missing the consensus of $0.08.
The healthcare commercial intelligence company reported sales of $65.93 million, up 9% Y/Y, missing the consensus of $66.02 million.
In the fourth quarter, Definitive Healthcare grew its enterprise client base by 28, or 5% Y/Y, ending the quarter with 565 enterprise customers, defined as those customers with more than $100,000 in annual recurring revenue.
Guidance: Definitive Health expects first quarter fiscal year 2024 revenue of $63 million-$65 million compared to the consensus of $65.70 million.
The company sees adjusted EPS of $0.07-$0.08 compared to consensus of $0.07, with adjusted operating income of $18.0 million-$19.0 million and adjusted EBITDA of $19.5 million-$20.5 ...